High levels of HIV envelope glycoprotein (Env) diversity have been associated with the development of broadly neutralizing antibodies (bNAbs). Here, we compare chronically HIV-1 infected subjects who develop bNAbs with those who did not, to assess whether lack of breadth can be attributed to low levels of viral diversity. Env nucleotide sequences were generated using Single Genome Amplification from four CAPRISA 002 cohort participants. Two participants developed neutralization breadth (CAP256 and CAP257) whereas the other two did not (CAP88 and CAP228) despite equivalently long duration of infection. Longitudinal diversity analyses were performed using Sequence Demarcation Tool (SDT). Phylogenetic analyses were performed using Bayesian Evolutionary Analysis by Sampling Trees (BEAST) software. Overall diversity increased with time in all subjects, as expected. Highest diversity was observed in CAP256 and CAP228, followed by CAP257 and least diversity in CAP88. The highest nucleotide substitution rates were observed in CAP257 (2.63 substitutions/100 nucleotides/year), CAP256 (2.28 subs/100n/yr.) and CAP228 (2.07 subs/100n/yr.), and the lowest in CAP088 (0.99 subs/100n/yr.). The time to the most recent common ancestor (tMRCA) inferred from BEAST was longer than the actual time of infection for CAP256 and CAP228, suggesting the possibility of super-infection or multivariant infection. We conclude that the absence of viral diversity may limit bNAb development, as in CAP88. However, increased diversity through high mutation rates and/or recombination, while likely necessary, is not sufficient for driving the development of bNAbs.
